Although no involvement of S1P2 in the pathogenesis of AD has been reported, S1P5 is widely expressed in the CNS, and in one study, an S1P5 agonist was demonstrated to attenuate age-related cognitive decline in mice (Hobson et al., 2015). The gene discussed is S1PR2; the disease is Alzheimer disease.